Company



Bridge4Bio Expands Globally and Adds Market Segments

Kensington, CA, United States, June 25, 2009 - Bridge4Bio, an international business consultancy group focusing on the growth of life sciences and biotechnology companies has added 4 new key personnel to the bridge4bio business. With four new senior consultants joining the company brings even further depth and understanding in the pharmaceutical, biotech, diagnostic
and drug discovery markets.

Tiina Sepp has joined as a senior consulting partner. Based in the USA has more than 16 years of research and business experience with a broad scientific background in virology, as well as molecular and cell biology. She completed her graduate studies in Munich, followed by a postdoctoral fellowship at University of California San Francisco. After transferring to the biotech industry, Tiina has held various technical and business management positions with Amersham Biosciences, BD Biosciences, Clontech and Invitrogen Corporation as well as in fast-paced startup companies.

Rachel Gabay has joined as a senior consulting partner. Based in Israel Rachel brings more than 13 years of management experience in strategic international marketing and product management for pharmaceutical and biotechnology companies, including Teva Pharmaceutical, Biogen and Eli Lilly. She has launched international marketing campaigns and provided consultation in business analysis, market evaluation and intellectual property strategy. Rachel has a MSc. in Developmental Biology from Hebrew University and an MBA from The College of Management–Academic Studies Division, Israel.

Neil Winterbottom has joined as a senior consulting partner. Based in the USA Neil has led medical device, diagnostic and combination product R&D teams from concept to commercialization for more than 18 years, including more than five years launching new ventures. He’s played a scientific and technical role for regulatory, business development, manufacturing, quality, sales and marketing groups at companies from start-ups to multinationals (Metra Biosystems, Fusion Medical Technologies, Baxter Healthcare). His most recent position was VP of R&D at Tenaxis Medical. Neil holds a B.Sc. in Biological Sciences from Manchester Polytechnic in the UK and a Ph.D. in Oral Biology (Biochemistry) from the University of Alberta, Canada. He also has significant experience in managing the environmental, health and safety systems of biotech and medical businesses.

Mark Daniels Has joined as a senior consulting partner. Mark brings more than 30 years experience in life sciences, with an R&D background in academic research, technology development and biopharmaceuticals in the San Francisco Bay Area (Cetus, California Biotechnology, Pharmacia Biotech). Mark has spent the past 20 years supporting and developing global business development, including the past 13 years on the ground in Asia as general manager in Southeast Asia for Amersham/GE Healthcare, then as director of the Bionoetikos consulting group. His expertise includes Asian emerging markets, new business start-ups, distribution development and negotiation support for bioscience companies.

Hugh Douglas President, commented “These consultants who have all first-hand faced the challenges for start-ups and growth by life sciences and biotechnology businesses, Bring Bridge4Bio into the global market.arena.”

 

Media Contact
Phoenix MarCom Ltd
Tel: + 44 (0) 1223 873318
Fax: + 44 (0) 1223 874173
Email: marketing@phoenixmarcom.co.uk

Bridge4Bio, LLC
32 Kerr Avenue, Kensington CA 94707, USA
Tel: +1 510 559 8599 - Email: press@bridge4bio.com Website: www.bridge4bio.com

 

Information for Editors

Bridge4Bio is a business consultancy group focused on promoting the growth of life science companies.
President, Hugh Douglas offers more than 20 years of experience in managing general operations, manufacturing, R&D, finance and administration, and marketing and business development. Douglas, who was formerly the managing director/president of Hoefer, Inc., a global electrophoresis company, as well as vice president of West Coast Operations for Amersham Biosciences, also has experience in acquisitions and raising capital for new ventures.

Headquartered in the San Francisco Bay Area, Bridge4Bio maintains satellite offices in Sweden, United Kingdom, Israel, Southeast Asia, and India.

Contact Us Today »

Download our Fact Sheet:

Bridge4Bio serves many sectors including:

  • Drug discovery
  • Academic research
  • Biotech
  • Medical devices
  • Diagnostics
  • Pharmaceuticals